

Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing. ARCH Venture Partners and UCB Ventures led the round.
Source: Press Release
Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing.
Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing. ARCH Venture Partners and UCB Ventures led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination